Your search for ‘Norton Rose Fulbright LLP’ returned 1,189 results

Cette signature couronne de succès les longues négociations qui ont duré plus de cinq ans et qui ont mené à la ratification de l’entente.

Toute invention brevetée résulte d'abord et avant tout du travail créatif d'un individu, ou d'un ensemble d'individus.

On November 15, 2013, the Supreme Court of Canada released its decision in Alberta (Information and Privacy Commissioner) v United Food and Commercial Workers, Local 4011. Since leave to appeal was granted in October 2012 ..

En novembre l'an dernier, la Fédération des syndicats de l'enseignement (ci-après « FSE ») faisait connaître ses demandes syndicales en vue de l'année de négociation nationale qui débutait pour les enseignantes et enseignants québécois ..

The Competition Bureau made several significant announcements in September that affect the pharmaceuticals and life sciences sectors.

Eight months after the announcement of Loblaw Companies’s proposed acquisition of Shoppers Drug Mart, the Competition Bureau concluded its review.

Last month Canada’s Competition Bureau (the Bureau) released its updated Information Bulletin on the Communication of Confidential Information under the Competition Act (the New Policy).

Institutional Shareholder Services Inc. (ISS) and Glass Lewis have issued their Canadian proxy voting guidelines for the upcoming proxy season.

On April 21, 2015, the Government of Canada tabled the federal budget, Economic Action Plan 2015 (Budget 2015) in the House of Commons. In Budget 2015.

The Nagoya Protocol on Access and Benefit-sharing (the Protocol), adopted in 2010 by the parties to the Convention on Biological Diversity (the Convention), entered into force in October 2014.

The policy aims to prevent medication errors that can occur in practice given similarity between product names.

Sanofi-Aventis (Sanofi) markets and sells oxaliplatin, used for the treatment of life-threatening colorectal cancer, in Canada under the brand name ELOXATIN® for use in the treatment of colorectal cancer.

Allergan obtained a prohibition order against Apotex under section 6 of the PMNOC Regulations with respect to the drug bimatoprost and Canadian Patent No. 2,585,691

Horizon Pharma PLC is seeking approval to market the drug RAVICTI (glycerol phenylbutyrate) for the treatment of urea cycle disorders.

Many of the provisions of Canada’s law governing commercial electronic messages (CEMs) will come into effect on July 1, 2014.

The federal government's procurement department, Public Works and Government Services Canada (PWGSC), recently amended its integrity regime for bidders and contractors seeking to enter into contracts with the federal government.

Under Article 2503 of the Civil Code of Québec, a liability insurer is bound to assume the defence costs resulting from actions that are taken against its insured and covered by the insured’s insurance policy.